统一为英语的描述性的题目与摘要地保护其发明创造，在专利文献中往往会用一些上位、繁复嗨涩的术语（或法律术语），与一般科技论文中的通用技术用词不同，因此用习惯的常用词检索时，很难找全相关的技术专利文献，了解某项技术的全貌Derwent的技术专家会用通俗的语言按照技术人员平常用词、行文的习惯重新用英文书写每一篇文献的标题和摘要，重新书写的标题、摘要会从以下几个方面对专利加以描述，即使用习惯的常用词进行检索，也不会有问题
信息检索与利用 统一为英语的描述性的题目与摘要 地保护其发明创造，在专利文献中往往会用一些上位、 繁复晦涩的术语（或法律术语），与一般科技论文中的 通用技术用词不同，因此用习惯的常用词检索时，很难 找全相关的技术专利文献，了解某项技术的全貌 • Derwent的技术专家会用通俗的语言按照技术人员平常用 词、行文的习惯重新用英文书写每一篇文献的标题和摘 要，重新书写的标题、摘要会从以下几个方面对专利加 以描述，即使用习惯的常用词进行检索，也不会有问题
描述性的题目Derwent描述性标题专利文献原标题："Seedling setting machine"Setting machine"has transportation unit forusing vacuum to suckwithdrawn seedling intopredetermined position信息检索与利用
信息检索与利用 专利文献原标题： “Setting machine” Derwent 描述性标题 “Seedling setting machine - has transportation unit for using vacuum to suck withdrawn seedling into predetermined position” 描述性的题目
描述性的摘要Derwent描述性摘要专利文献原摘要Capsule(A)comprises a core containing antibodyproducing cells (B), surrounded by a porous wall thatThe present inventionispermeabletoantibodies(Ab)producedbythecells.relates to capsulesencapsulating antibody.UsE-Abmaybind toandblock thereceptors essentialproducing cells, and toforviral infection,ortheybindto viruses orothertheuseof suchcapsulescirculatingantigens. The capsules are implantedfortreatment orprevention of disease,particularlyand encapsulated cells,cancerautoimmune disease (including multiplesclerosis..ADVANTAGE-respectively.forimplantation invivo forlongterm delivery or sustained delivery ofantibodies of therapeutic interest.Thecapsules, from whichno anti-idiotype responseiselicitedprovidelong-term orsustainedreleaseofAbandafterimplantation donotcauseaninflammatoryresponse in thehost....信息检索与利用
信息检索与利用 描述性的摘要 Derwent 描述性摘要 Capsule (A) comprises a core containing antibodyproducing cells (B), surrounded by a porous wall that is permeable to antibodies (Ab) produced by the cells. USE - Ab may bind to and block the receptors essential for viral infection, or they bind to viruses or other circulating antigens. The capsules are implanted for treatment or prevention of disease, particularly cancer, autoimmune disease (including multiple sclerosis . ADVANTAGE - respectively, for implantation in vivo for long term delivery or sustained delivery of antibodies of therapeutic interest. ⚫ The capsules, from which no anti-idiotype response is elicited provide long-term or sustained release of Ab and after implantation do not cause an inflammatory response in the host. 专利文献原摘要 The present invention relates to capsules encapsulating antibodyproducing cells, and to the use of such capsules and encapsulated cells